| 臺大學術典藏 |
2021-08-23T01:35:58Z |
Unrecognized Voiding Difficulty in Female Type 2 Diabetic Patients in the Diabetes Clinic: A prospective case-control study
|
Yu H.-J.; Lee W.-C.; Liu S.-P.; Tai T.-Y.; HUEY-PEIR WU; Chen J. |
| 臺大學術典藏 |
2021-08-03T03:49:11Z |
The combination of blood flow velocity and vascular diameter: The Arterial Flow Index is a better parameter in the evaluation of arteriogenic erectile dysfunction
|
Huang, W-L.; Tung, S-Y; CHI-SHIN TSENG; Wang, T-D; Lee, W-J; Liu, S-P; Hsieh, J-T; Chang, H-C; Chang, Y-K |
| 臺大學術典藏 |
2021-08-02T02:32:51Z |
Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes
|
Ho C.-H.; Liao P.-W.; Lin V.C.; Jaw F.-S.; SHIH-CHIEH CHUEH; Chung S.-D.; Liu S.-P.; Tsai Y.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-07-06T07:01:23Z |
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
|
Hsu J.-L.; Liu S.-P.; Lee C.-C.; LIH-CHING HSU; Ho Y.-F.; Huang H.-S.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:22Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; LIH-CHING HSU; Chang W.-L.; Chao C.C.-K.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:19Z |
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
|
Leu W.-J.;Swain S.P.;Chan S.-H.;Hsu J.-L.;Liu S.-P.;Chan M.-L.;Yu C.-C.;Lih-Ching Hsu;Chou Y.-L.;Chang W.-L.;Hou D.-R.;Guh J.-H.; Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; Liu S.-P.; Chan M.-L.; Yu C.-C.; LIH-CHING HSU; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:18Z |
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
|
Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; LIH-CHING HSU; Liu S.-P.; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:16Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Lih-Ching Hsu;Liu S.-P.;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; LIH-CHING HSU; Liu S.-P.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:16Z |
Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents
|
Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Liu S.-P.; Zhong N.-S.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:14Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Ho C.-H.; Liu S.-P.; Guh J.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Chia-Chun Wang; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; Chia-Chun Wang; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Chia-Chun Wang; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:26Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:25Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:24Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-02T05:43:40Z |
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
|
Hsu J.-L.; Liu S.-P.; Lee C.-C.; Hsu L.-C.; Ho Y.-F.; Huang H.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:37Z |
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i
|
Yu C.-C.; Pan S.-L.; Chao S.-W.; Liu S.-P.; Hsu J.-L.; Yang Y.-C.; Li T.-K.; Huang W.-J.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:35Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; Hsu L.-C.; Chang W.-L.; Chao C.C.-K.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:34Z |
KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora a activity
|
Yu C.-C.; Liu S.-P.; Hsu J.-L.; Hsu J.T.A.; Kudryavtsev K.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:32Z |
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
|
Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; Liu S.-P.; Chan M.-L.; Yu C.-C.; Hsu L.-C.; Chou Y.-L.; Chang W.-L.; Hou D.-R.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:30Z |
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
|
Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; Hsu L.-C.; Liu S.-P.; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:27Z |
Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents
|
Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Liu S.-P.; Zhong N.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:26Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Liu S.-P.;Jih-Hwa Guh; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; Liu S.-P.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:17Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Ho C.-H.;Liu S.-P.;Jih-Hwa Guh; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; Liu S.-P.; JIH-HWA GUH |
